Why the study?
Increasing surgical and transcatheter heart valve replacements lead to higher prosthetic valve endocarditis, prompting a comparison of infective endocarditis incidence between TAVI and SAVR, along with risk factors and treatment strategies.
Does TAVI compared to SAVR alter the incidence of infective endocarditis in patients requiring aortic valve replacement?
Population
Patients across 68 selected publications
Comparison
TAVI vs SAVR
Design
Meta-analysis and systematic review
Authors
Loading...
Similar IE incidence after TAVI and SAVR; observational data leave open whether surgery improves TAVI-IE survival.
Does TAVI compared to SAVR alter the incidence of infective endocarditis in patients requiring aortic valve replacement?
TAVI and SAVR carry similar risks of infective endocarditis, though TAVI-IE is associated with high mortality (38.3%) and specific risk factors including male gender, intubation, new pacemaker, and CKD.
Tinică et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: